Company Filing History:
3 out of 96 
3 out of 321 
3 out of 13 
Years Active: 2013-2014
Title: Valérie Ugo: Innovator in Hematology
Introduction
Valérie Ugo is a prominent inventor based in Paris, France. He has made significant contributions to the field of hematology, particularly in understanding and diagnosing myeloproliferative disorders. With a total of 3 patents, his work has had a profound impact on medical diagnostics.
Latest Patents
Valérie Ugo's latest patents include groundbreaking inventions related to the JAK2 mutation. One of his notable patents is focused on the identification of the JAK2 V617F variant, which is responsible for Vaquez Polyglobulia. This invention provides a first intention diagnostic method for erythrocytosis and thrombocytosis, allowing for their association with myeloproliferative disorders. Additionally, it facilitates the detection of the JAK2 V617F variant in these disorders, enabling their reclassification into a new nosological group. Another patent addresses the identification of the same JAK2 mutation in polycythemia vera, further emphasizing its relevance in hematological conditions.
Career Highlights
Throughout his career, Valérie Ugo has worked with esteemed institutions such as the Institut Gustave Roussy and Assistance Publique-Hôpitaux de Paris. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Valérie Ugo has collaborated with notable professionals, including William Vainchenker and Jean-Pierre Le Couedic. These partnerships have enriched his research and expanded the impact of his inventions in the medical community.
Conclusion
Valérie Ugo's innovative work in identifying JAK2 mutations has paved the way for improved diagnostic methods in hematology. His contributions continue to influence the understanding and treatment of myeloproliferative disorders.